190 related articles for article (PubMed ID: 20569710)
21. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Johnson BD; Shaw LJ; Buchthal SD; Bairey Merz CN; Kim HW; Scott KN; Doyle M; Olson MB; Pepine CJ; den Hollander J; Sharaf B; Rogers WJ; Mankad S; Forder JR; Kelsey SF; Pohost GM;
Circulation; 2004 Jun; 109(24):2993-9. PubMed ID: 15197152
[TBL] [Abstract][Full Text] [Related]
22. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
Letterie GS
Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
[TBL] [Abstract][Full Text] [Related]
23. Short-term hormone treatment modulates emotion response circuitry in postmenopausal women.
Love T; Smith YR; Persad CC; Tkaczyk A; Zubieta JK
Fertil Steril; 2010 Apr; 93(6):1929-37. PubMed ID: 19243753
[TBL] [Abstract][Full Text] [Related]
24. Hormone replacement, race, and psychological health in women: a report from the NHLBI-Sponsored WISE Study.
Olson MB; Bairey Merz CN; Shaw LJ; Mankad S; Reis SE; Pohost GM; Smith KM; McGorray SP; Cornell CE; Kelsey SF;
J Womens Health (Larchmt); 2004 Apr; 13(3):325-32. PubMed ID: 15130261
[TBL] [Abstract][Full Text] [Related]
25. A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement.
Williams SR; Frenchek B; Speroff T; Speroff L
Am J Obstet Gynecol; 1990 Feb; 162(2):438-46. PubMed ID: 2309827
[TBL] [Abstract][Full Text] [Related]
26. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
[TBL] [Abstract][Full Text] [Related]
27. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
Manson JE; Chlebowski RT; Stefanick ML; Aragaki AK; Rossouw JE; Prentice RL; Anderson G; Howard BV; Thomson CA; LaCroix AZ; Wactawski-Wende J; Jackson RD; Limacher M; Margolis KL; Wassertheil-Smoller S; Beresford SA; Cauley JA; Eaton CB; Gass M; Hsia J; Johnson KC; Kooperberg C; Kuller LH; Lewis CE; Liu S; Martin LW; Ockene JK; O'Sullivan MJ; Powell LH; Simon MS; Van Horn L; Vitolins MZ; Wallace RB
JAMA; 2013 Oct; 310(13):1353-68. PubMed ID: 24084921
[TBL] [Abstract][Full Text] [Related]
28. Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease.
Braunstein GD; Johnson BD; Stanczyk FZ; Bittner V; Berga SL; Shaw L; Hodgson TK; Paul-Labrador M; Azziz R; Merz CN
J Clin Endocrinol Metab; 2008 Nov; 93(11):4268-75. PubMed ID: 18728170
[TBL] [Abstract][Full Text] [Related]
29. DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Shufelt C; Bretsky P; Almeida CM; Johnson BD; Shaw LJ; Azziz R; Braunstein GD; Pepine CJ; Bittner V; Vido DA; Stanczyk FZ; Bairey Merz CN
J Clin Endocrinol Metab; 2010 Nov; 95(11):4985-92. PubMed ID: 20739385
[TBL] [Abstract][Full Text] [Related]
30. Brachial artery constriction during brachial artery reactivity testing predicts major adverse clinical outcomes in women with suspected myocardial ischemia: results from the NHLBI-sponsored women's ischemia Syndrome Evaluation (WISE) Study.
Sedlak TL; Johnson BD; Pepine CJ; Reis SE; Bairey Merz CN
PLoS One; 2013; 8(9):e74585. PubMed ID: 24058592
[TBL] [Abstract][Full Text] [Related]
31. Does menopausal hormone therapy (MHT), exercise or a combination of both, improve pain and function in post-menopausal women with greater trochanteric pain syndrome (GTPS)? A randomised controlled trial.
Ganderton C; Semciw A; Cook J; Pizzari T
BMC Womens Health; 2016 Jun; 16():32. PubMed ID: 27312538
[TBL] [Abstract][Full Text] [Related]
32. Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study.
Bruhat M; Rudolf K; Vaheri R; Kainulainen P; Timonen U; Viitanen A
Maturitas; 2001 Dec; 40(3):259-71. PubMed ID: 11731187
[TBL] [Abstract][Full Text] [Related]
33. Dehydroepiandrosterone for women in the peri- or postmenopausal phase.
Scheffers CS; Armstrong S; Cantineau AE; Farquhar C; Jordan V
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD011066. PubMed ID: 25879093
[TBL] [Abstract][Full Text] [Related]
34. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.
Graham CA; Sherwin BB
J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678
[TBL] [Abstract][Full Text] [Related]
35. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
Ruiz AD; Daniels KR
Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
[TBL] [Abstract][Full Text] [Related]
36. Assessment of women with suspected myocardial ischemia: review of findings of the Women's Ischemia Syndrome Evaluation (WISE) Study.
Lewis JF; McGorray SP; Pepine CJ
Curr Womens Health Rep; 2002 Apr; 2(2):110-4. PubMed ID: 12116599
[TBL] [Abstract][Full Text] [Related]
37. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.
Schierbeck LL; Rejnmark L; Tofteng CL; Stilgren L; Eiken P; Mosekilde L; Køber L; Jensen JE
BMJ; 2012 Oct; 345():e6409. PubMed ID: 23048011
[TBL] [Abstract][Full Text] [Related]
38. Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial.
Quigley CA; Wan X; Garg S; Kowal K; Cutler GB; Ross JL
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1754-64. PubMed ID: 24762109
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).
Anderson RD; Petersen JW; Mehta PK; Wei J; Johnson BD; Handberg EM; Kar S; Samuels B; Azarbal B; Kothawade K; Kelsey SF; Sharaf B; Shaw LJ; Sopko G; Bairey Merz CN; Pepine CJ
J Interv Cardiol; 2019; 2019():7169275. PubMed ID: 31772544
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
Zhou YZ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Lin SQ
Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
